VERACYTE INC (VCYT) — insider trading
Health Care · NASDAQ
VERACYTE INC (VCYT) has 46 reported SEC Form 4 insider transactions in our data, including 21 open-market sales among the most recent 46 (latest 2026-09-21).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-21 | Leite John | Officer (Global Chief Commercial Off) | Open-market sale | 4,015 | $40.00 | $160.6K | Form 4 |
| 2026-09-14 | Holstein Jens | Director | Open-market sale | 5,000 | $40.95 | $204.7K | Form 4 |
| 2026-09-04 | McGuire Annie | Officer (EVP, General Counsel) | Open-market sale | 1,100 | $43.67 | $48.0K | Form 4 |
| 2026-09-04 | McGuire Annie | Officer (EVP, General Counsel) | Open-market sale | 2,154 | $42.79 | $92.2K | Form 4 |
| 2026-09-04 | Febbo Phillip G. | Officer (Chief Scientific & Med Officer) | Open-market sale | 2,705 | $43.66 | $118.1K | Form 4 |
| 2026-09-04 | Febbo Phillip G. | Officer (Chief Scientific & Med Officer) | Open-market sale | 10,405 | $42.89 | $446.3K | Form 4 |
| 2026-09-04 | Chambers Rebecca | Officer (Chief Financial Officer) | Open-market sale | 1,175 | $43.71 | $51.4K | Form 4 |
| 2026-09-04 | Chambers Rebecca | Officer (Chief Financial Officer) | Open-market sale | 2,477 | $42.81 | $106.0K | Form 4 |
| 2026-09-02 | Wygant Jonathan | Officer (VP, Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 1,361 | $44.88 | $61.1K | Form 4 |
| 2026-09-02 | Stapley Marc | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 8,782 | $44.88 | $394.1K | Form 4 |
| 2026-09-02 | McGuire Annie | Officer (EVP, General Counsel) | Shares withheld for taxes / exercise cost | 3,215 | $44.88 | $144.3K | Form 4 |
| 2026-09-02 | Leite John | Officer (Global Chief Commercial Off) | Shares withheld for taxes / exercise cost | 3,961 | $44.88 | $177.8K | Form 4 |
| 2026-09-02 | Febbo Phillip G. | Officer (Chief Scientific & Med Officer) | Shares withheld for taxes / exercise cost | 3,639 | $44.88 | $163.3K | Form 4 |
| 2026-09-02 | Chambers Rebecca | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 3,603 | $44.88 | $161.7K | Form 4 |
| 2026-09-01 | Bhanji Muna | Director | Open-market sale | 1,864 | $42.97 | $80.1K | Form 4 |
| 2026-06-18 | EASTHAM KARIN | Director | Open-market sale | 529 | $53.55 | $28.3K | Form 4 |
| 2026-06-18 | EASTHAM KARIN | Director | Open-market sale | 3,200 | $52.78 | $168.9K | Form 4 |
| 2026-06-11 | Miller Thomas F. | Director | Grant / award / vesting | 5,272 | — | $0 | Form 4 |
| 2026-06-11 | Bhanji Muna | Director | Grant / award / vesting | 5,272 | — | $0 | Form 4 |
| 2026-06-11 | Holstein Jens | Director | Grant / award / vesting | 5,272 | — | $0 | Form 4 |
| 2026-06-11 | EPSTEIN ROBERT S | Director | Grant / award / vesting | 5,272 | — | $0 | Form 4 |
| 2026-06-11 | Barr Eliav | Director | Grant / award / vesting | 5,272 | — | $0 | Form 4 |
| 2026-06-11 | Shafer David Brent | Director | Grant / award / vesting | 5,272 | — | $0 | Form 4 |
| 2026-06-11 | JONES EVAN/ FA | Director | Grant / award / vesting | 5,272 | — | $0 | Form 4 |
| 2026-06-11 | EASTHAM KARIN | Director | Grant / award / vesting | 5,272 | — | $0 | Form 4 |
| 2026-06-04 | Leite John | Officer (Global Chief Commercial Off) | Open-market sale | 13,975 | $50.07 | $699.7K | Form 4 |
| 2026-06-04 | Stapley Marc | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 138,051 | — | $0 | Form 4 |
| 2026-06-04 | Stapley Marc | Director, Officer (Chief Executive Officer) | Open-market sale | 138,051 | $50.12 | $6.92M | Form 4 |
| 2026-06-04 | Stapley Marc | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 138,051 | $36.60 | $5.05M | Form 4 |
| 2026-06-04 | Chambers Rebecca | Officer (Chief Financial Officer) | Open-market sale | 1,961 | $50.09 | $98.2K | Form 4 |
| 2026-06-04 | Chambers Rebecca | Officer (Chief Financial Officer) | Open-market sale | 1,600 | $49.28 | $78.9K | Form 4 |
| 2026-06-04 | McGuire Annie | Officer (EVP, General Counsel) | Open-market sale | 1,776 | $50.12 | $89.0K | Form 4 |
| 2026-06-04 | McGuire Annie | Officer (EVP, General Counsel) | Open-market sale | 1,400 | $49.31 | $69.0K | Form 4 |
| 2026-06-02 | Leite John | Officer (Global Chief Commercial Off) | Shares withheld for taxes / exercise cost | 4,059 | $47.80 | $194.0K | Form 4 |
| 2026-06-02 | Stapley Marc | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 9,012 | $47.80 | $430.8K | Form 4 |
| 2026-06-02 | Febbo Phillip G. | Officer (Chief Scientific & Med Officer) | Shares withheld for taxes / exercise cost | 3,730 | $47.80 | $178.3K | Form 4 |
| 2026-06-02 | Chambers Rebecca | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 3,693 | $47.80 | $176.5K | Form 4 |
| 2026-06-02 | Wygant Jonathan | Officer (VP, Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 1,361 | $47.80 | $65.1K | Form 4 |
| 2026-06-02 | McGuire Annie | Officer (EVP, General Counsel) | Shares withheld for taxes / exercise cost | 3,292 | $47.80 | $157.4K | Form 4 |
| 2026-05-22 | Wygant Jonathan | Officer (VP, Chief Accounting Officer) | Option exercise / conversion (derivative) | 24,000 | — | $0 | Form 4 |
| 2026-05-22 | Wygant Jonathan | Officer (VP, Chief Accounting Officer) | Open-market sale | 24,000 | $45.40 | $1.09M | Form 4 |
| 2026-05-22 | Wygant Jonathan | Officer (VP, Chief Accounting Officer) | Option exercise / conversion | 24,000 | $24.80 | $595.2K | Form 4 |
| 2026-05-20 | EPSTEIN ROBERT S | Director | Open-market sale | 10,000 | $44.01 | $440.1K | Form 4 |
| 2026-05-06 | McGuire Annie | Officer (SVP, General Counsel) | Open-market sale | 5,102 | $40.00 | $204.1K | Form 4 |
| 2026-05-06 | McGuire Annie | Officer (SVP, General Counsel) | Open-market sale | 5,102 | $38.05 | $194.1K | Form 4 |
| 2026-04-10 | Haas Kevin Richard | Officer (Chief Dev and Tech Officer) | Grant / award / vesting | 44,221 | — | $0 | Form 4 |
Ask the chat about VCYT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: VERACYTE INC (VCYT).
Last updated 2026-09-21 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.